{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T06:35:28Z","timestamp":1793946928441,"version":"4.8.0"},"reference-count":38,"publisher":"Oxford University Press (OUP)","issue":"3","license":[{"start":{"date-parts":[[2019,10,28]],"date-time":"2019-10-28T00:00:00Z","timestamp":1572220800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"funder":[{"DOI":"10.13039\/501100006484","name":"Vifor Pharma","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006484","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2020,3,13]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Background and Aims<\/jats:title><jats:p>Anaemia is common in patients with inflammatory bowel disease [IBD], its two main aetiologies being iron deficiency anaemia [IDA] and anaemia of chronic inflammation [ACI]. Impaired intestinal iron absorption due to inflammatory cytokines is thought to play a role in ACI. We undertook for the first time a controlled prospective study investigating effects of differing underlying diseases, disease locations, and types of iron deficiency or anaemia on oral iron absorption in adult IBD patients with and without inflammation.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>This study was a comparative, single-centred open clinical trial in adults with IBD [n = 73] and healthy controls [n = 22]. Baseline parameters included blood count, iron status [ferritin, transferrin, transferrin saturation, soluble transferrin receptor, hepcidin, serum iron], high-sensitivity C-reactive protein [hsCRP] and interleukin-6. Iron absorption was tested using one oral, enteric-coated capsule containing 567.7 mg iron[II]-glycine-sulphate complex. Serum iron was determined 60\/90\/120\/180\/240 min after ingestion.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Iron absorption capacity was shown to be influenced by inflammation and anaemia or iron deficiency [ID] type but not by underlying disease type or localisation. The ACI group showed a significantly lower iron absorption capacity than all others. Whereas hsCRP levels [-0.387, p &amp;lt; 0.001], IL-6 [-0.331, p = 0.006], ferritin [-0.531, p &amp;lt; 0.001], and serum hepcidin [-0.353, p = 0.003] correlated negatively with serum iron change at 2 h, transferrin showed a positive correlation at the same time point [0.379, p &amp;lt; 0.001].<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>Underlying disease type and localisation appear to have little effect on iron absorption capacity, whereas lack of response to oral iron correlates well with serum markers of inflammation. Iron absorption capacity is thus significantly reduced in the presence of inflammation.<\/jats:p><\/jats:sec>","DOI":"10.1093\/ecco-jcc\/jjz149","type":"journal-article","created":{"date-parts":[[2019,10,17]],"date-time":"2019-10-17T11:12:12Z","timestamp":1571310732000},"page":"316-322","source":"Crossref","is-referenced-by-count":24,"title":["Inflammation, but Not the Underlying Disease or Its Location, Predicts Oral Iron Absorption Capacity in Patients With Inflammatory Bowel Disease"],"prefix":"10.1093","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2819-3484","authenticated-orcid":false,"given":"Ay\u015feg\u00fcl","family":"Aksan","sequence":"first","affiliation":[{"name":"Interdisciplinary Crohn-Colitis Centre Rhein-Main, Frankfurt am Main, Germany"},{"name":"Institute of Pharmaceutical Chemistry, Goethe University Frankfurt am Main, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Wohlrath","sequence":"first","affiliation":[{"name":"Interdisciplinary Crohn-Colitis Centre Rhein-Main, Frankfurt am Main, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tariq H","family":"Iqbal","sequence":"first","affiliation":[{"name":"Institute for Cancer Studies, University of Birmingham Cancer Research, Birmingham, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9724-054X","authenticated-orcid":false,"given":"A","family":"Dignass","sequence":"first","affiliation":[{"name":"Department of Gastroenterology, Apaglesion Markus Krankenhaus, Frankfurt am Main, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3558-3341","authenticated-orcid":false,"given":"J","family":"Stein","sequence":"first","affiliation":[{"name":"Interdisciplinary Crohn-Colitis Centre Rhein-Main, Frankfurt am Main, Germany"},{"name":"Department of Gastroenterology and Clinical Nutrition, DGD Clinics Sachsenhausen, Frankfurt am Main, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2019,10,28]]},"reference":[{"key":"2020042909360557900_CIT0001","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1097\/MEG.0000000000000200","article-title":"Anaemia from a patient perspective in inflammatory bowel disease: results from the European Federation of Crohn\u2019s and Ulcerative Colitis Association\u2019s online survey","volume":"26","author":"Danese","year":"2014","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"2020042909360557900_CIT0002","doi-asserted-by":"crossref","first-page":"1456","DOI":"10.1097\/MEG.0b013e328365ca7f","article-title":"Anaemia management in patients with inflammatory bowel disease: routine practice across nine European countries","volume":"25","author":"Stein","year":"2013","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"2020042909360557900_CIT0003","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.1016\/j.crohns.2014.03.010","article-title":"Current practice in the diagnosis and management of IBD-associated anaemia and iron deficiency in Germany: the German AnaemIBD Study","volume":"8","author":"Blumenstein","year":"2014","journal-title":"J Crohns Colitis"},{"key":"2020042909360557900_CIT0004","doi-asserted-by":"crossref","first-page":"304","DOI":"10.3109\/00365521.2010.533382","article-title":"The prevalence of anemia and iron deficiency in IBD outpatients in Scandinavia","volume":"46","author":"Bager","year":"2011","journal-title":"Scand J Gastroenterol"},{"key":"2020042909360557900_CIT0005","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1016\/j.crohns.2010.07.008","article-title":"Prevalence of anaemia in inflammatory bowel disease in Switzerland: a cross-sectional study in patients from private practices and university hospitals","volume":"4","author":"Voegtlin","year":"2010","journal-title":"J Crohns Colitis"},{"key":"2020042909360557900_CIT0006","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1002\/ibd.21740","article-title":"Prevalence and management of anemia in children, adolescents, and adults with inflammatory bowel disease","volume":"18","author":"Goodhand","year":"2012","journal-title":"Inflamm Bowel Dis"},{"key":"2020042909360557900_CIT0007","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1007\/s11938-015-0062-y","article-title":"Anaemia in the elderly IBD patient","volume":"13","author":"Stein","year":"2015","journal-title":"Curr Treat Options Gastroenterol"},{"key":"2020042909360557900_CIT0008","doi-asserted-by":"crossref","first-page":"937","DOI":"10.3109\/00365521.2012.672590","article-title":"Low prevalence of anemia in inflammatory bowel disease: a population-based study in Sweden","volume":"47","author":"Rejler","year":"2012","journal-title":"Scand J Gastroenterol"},{"key":"2020042909360557900_CIT0009","volume-title":"Assessing Chronic Disease Management in European Health Systems: Country Reports","author":"Nolte"},{"key":"2020042909360557900_CIT0010","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1016\/S0140-6736(15)60865-0","article-title":"Iron deficiency anaemia","volume":"387","author":"Lopez","year":"2016","journal-title":"Lancet"},{"key":"2020042909360557900_CIT0011","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.hoc.2015.11.002","article-title":"The global burden of anemia","volume":"30","author":"Kassebaum","year":"2016","journal-title":"Hematol Oncol Clin North Am"},{"key":"2020042909360557900_CIT0012","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1038\/nrgastro.2010.151","article-title":"Diagnosis and management of iron deficiency anemia in patients with IBD","volume":"7","author":"Stein","year":"2010","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"2020042909360557900_CIT0013","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/j.mcna.2016.09.005","article-title":"Anemia of inflammation: a review","volume":"101","author":"Fraenkel","year":"2017","journal-title":"Med Clin North Am"},{"key":"2020042909360557900_CIT0014","doi-asserted-by":"crossref","first-page":"S15","DOI":"10.1016\/j.jpeds.2015.07.015","article-title":"Pathophysiology of iron homeostasis during inflammatory states","volume":"167","author":"Cherayil","year":"2015","journal-title":"J Pediatr"},{"key":"2020042909360557900_CIT0015","first-page":"51","article-title":"The regulation of iron absorption and homeostasis","volume":"37","author":"Wallace","year":"2016","journal-title":"Clin Biochem Rev"},{"key":"2020042909360557900_CIT0016","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1097\/01.mib.0000235097.86360.04","article-title":"Impaired intestinal iron absorption in Crohn\u2019s disease correlates with disease activity and markers of inflammation","volume":"12","author":"Semrin","year":"2006","journal-title":"Inflamm Bowel Dis"},{"key":"2020042909360557900_CIT0017","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1172\/JCI200420945","article-title":"IL-6 mediates hypoferremia of inflammation by inducing the synthesis of the iron regulatory hormone hepcidin","volume":"113","author":"Nemeth","year":"2004","journal-title":"J Clin Invest"},{"key":"2020042909360557900_CIT0018","doi-asserted-by":"crossref","first-page":"4129","DOI":"10.1182\/blood-2011-04-351957","article-title":"Hepcidin regulation by innate immune and infectious stimuli","volume":"118","author":"Armitage","year":"2011","journal-title":"Blood"},{"key":"2020042909360557900_CIT0019","doi-asserted-by":"crossref","first-page":"1845","DOI":"10.4049\/jimmunol.1202716","article-title":"IL-22 regulates iron availability in vivo through the induction of hepcidin","volume":"191","author":"Smith","year":"2013","journal-title":"J Immunol"},{"key":"2020042909360557900_CIT0020","doi-asserted-by":"crossref","first-page":"R141","DOI":"10.1186\/ar4323","article-title":"Comparative evaluation of the effects of treatment with tocilizumab and TNF-\u03b1 inhibitors on serum hepcidin, anemia response and disease activity in rheumatoid arthritis patients","volume":"15","author":"Song","year":"2013","journal-title":"Arthritis Res Ther"},{"key":"2020042909360557900_CIT0021","doi-asserted-by":"crossref","first-page":"1806","DOI":"10.1017\/S0007114511004971","article-title":"Iron requirements based upon iron absorption tests are poorly predicted by haematological indices in patients with inactive inflammatory bowel disease","volume":"107","author":"Lomer","year":"2012","journal-title":"Br J Nutr"},{"key":"2020042909360557900_CIT0022","doi-asserted-by":"crossref","first-page":"649","DOI":"10.3109\/00365527809181777","article-title":"Iron absorption and serum ferritin in chronic inflammatory bowel disease","volume":"13","author":"Bartels","year":"1978","journal-title":"Scand J Gastroenterol"},{"key":"2020042909360557900_CIT0023","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1093\/ecco-jcc\/jjv242","article-title":"Serum hepcidin and iron absorption in paediatric inflammatory bowel disease","volume":"10","author":"Martinelli","year":"2016","journal-title":"J Crohns Colitis"},{"key":"2020042909360557900_CIT0024","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1136\/gut.2005.082909","article-title":"The Montreal classification of inflammatory bowel disease: controversies, consensus, and implications","volume":"55","author":"Satsangi","year":"2006","journal-title":"Gut"},{"key":"2020042909360557900_CIT0025","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1016\/0016-5085(92)90098-J","article-title":"Evidence for continuous stimulation of interleukin-6 production in Crohn\u2019s disease","volume":"102","author":"Gross","year":"1992","journal-title":"Gastroenterology"},{"key":"2020042909360557900_CIT0026","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1097\/00005176-199608000-00012","article-title":"Elevation of serum interleukin-6 but not serum-soluble interleukin-2 receptor in children with Crohn\u2019s disease","volume":"23","author":"Bross","year":"1996","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"2020042909360557900_CIT0027","volume-title":"Haemoglobin Concentrations for the Diagnosis of Anaemia and Assessment of Severity","author":"World Health Organization","year":"2011"},{"key":"2020042909360557900_CIT0028","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1093\/ecco-jcc\/jju009","article-title":"European consensus on the diagnosis and management of iron deficiency and anaemia in inflammatory bowel diseases","volume":"9","author":"Dignass","year":"2015","journal-title":"J Crohns Colitis"},{"key":"2020042909360557900_CIT0029","doi-asserted-by":"crossref","first-page":"S4","DOI":"10.2215\/CJN.01490506","article-title":"Assessing iron status: beyond serum ferritin and transferrin saturation","volume":"1[Suppl 1]","author":"Wish","year":"2006","journal-title":"Clin J Am Soc Nephrol"},{"key":"2020042909360557900_CIT0030","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1182\/blood-2003-03-0672","article-title":"Hepcidin, a key regulator of iron metabolism and mediator of anemia of inflammation","volume":"102","author":"Ganz","year":"2003","journal-title":"Blood"},{"key":"2020042909360557900_CIT0031","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1111\/j.1365-2036.2005.02700.x","article-title":"Efficacy and tolerability of oral iron therapy in inflammatory bowel disease: a prospective, comparative trial","volume":"22","author":"de Silva","year":"2005","journal-title":"Aliment Pharmacol Ther"},{"key":"2020042909360557900_CIT0032","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1007\/s10620-005-9036-6","article-title":"Ferrus calcium citrate is absorbed better than iron bisglycinate in patients with Crohn\u2019s disease, but not in healthy controls","volume":"51","author":"Chermesh","year":"2006","journal-title":"Dig Dis Sci"},{"key":"2020042909360557900_CIT0033","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1007\/s10620-014-3460-4","article-title":"Clinical significance of C-reactive protein levels in predicting responsiveness to iron therapy in patients with inflammatory bowel disease and iron deficiency anemia","volume":"60","author":"Iqbal","year":"2015","journal-title":"Dig Dis Sci"},{"key":"2020042909360557900_CIT0034","doi-asserted-by":"crossref","first-page":"2193","DOI":"10.1016\/0024-3205(90)90149-L","article-title":"Significant increase of interleukin 6 production in blood mononuclear leukocytes obtained from patients with active inflammatory bowel disease","volume":"47","author":"Suzuki","year":"1990","journal-title":"Life Sci"},{"key":"2020042909360557900_CIT0035","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1159\/000163637","article-title":"Activation of monocytes during inflammatory bowel disease","volume":"59","author":"Andus","year":"1991","journal-title":"Pathobiology"},{"key":"2020042909360557900_CIT0036","doi-asserted-by":"crossref","first-page":"G385","DOI":"10.1152\/ajpgi.00246.2003","article-title":"Hepcidin regulation of ferroportin 1 expression in the liver and intestine of the rat","volume":"286","author":"Yeh","year":"2004","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"2020042909360557900_CIT0037","doi-asserted-by":"crossref","first-page":"1392","DOI":"10.1016\/j.crohns.2014.04.008","article-title":"Serum hepcidin concentrations correlate with ferritin in patients with inflammatory bowel disease","volume":"8","author":"Mecklenburg","year":"2014","journal-title":"J Crohns Colitis"},{"key":"2020042909360557900_CIT0038","doi-asserted-by":"crossref","first-page":"2166","DOI":"10.1097\/MIB.0b013e31829a6e43","article-title":"Serum hepcidin in inflammatory bowel diseases: biological and clinical significance","volume":"19","author":"Bergamaschi","year":"2013","journal-title":"Inflamm Bowel Dis"}],"container-title":["Journal of Crohn's and Colitis"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/ecco-jcc\/advance-article-pdf\/doi\/10.1093\/ecco-jcc\/jjz149\/30317791\/jjz149.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/ecco-jcc\/article-pdf\/14\/3\/316\/32901454\/jjz149.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/ecco-jcc\/article-pdf\/14\/3\/316\/32901454\/jjz149.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,10,2]],"date-time":"2022-10-02T00:18:21Z","timestamp":1664669901000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ecco-jcc\/article\/14\/3\/316\/5608095"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,10,28]]},"references-count":38,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2019,10,28]]},"published-print":{"date-parts":[[2020,3,13]]}},"URL":"https:\/\/doi.org\/10.1093\/ecco-jcc\/jjz149","relation":{},"ISSN":["1873-9946","1876-4479"],"issn-type":[{"value":"1873-9946","type":"print"},{"value":"1876-4479","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2020,3]]},"published":{"date-parts":[[2019,10,28]]}}}